BCL2 and diffuse large B-cell lymphoma: The data revealed that Ki‐67 was highly expressed in 68.6% of cases, bcl‐2 in 32.8%, and p53 in 26.2%, with high Ki‐67 and p53 levels particularly associated with more aggressive DLBCL, indicating potentially poorer outcomes.29